BARACLUDE 0,05 mg/ml, solution buvable
solution buvable
orale
Autorisation active
Procédure centralisée
Commercialisée
6/26/2006
BRISTOL-MYERS SQUIBB PHARMA (IRLANDE)
Business Listing - September 04, 2021
This is a premium business listing. Stand out from the competition!